Cocaine Nasal Spray for Nasal Procedures
Cocaine nasal spray should NOT be used for nasal procedures; lidocaine combined with phenylephrine (co-phenylcaine) is the preferred alternative due to equivalent efficacy with superior safety. 1
Recommendation Against Cocaine Use
The 2020 Difficult Airway Society guidelines explicitly state that cocaine is not advised for topical anesthesia and vasoconstriction (Grade A recommendation). 1 The evidence demonstrates that cocaine's analgesic efficacy during nasotracheal tube insertion is no better than co-phenylcaine (lidocaine 5%/phenylephrine 0.5%), while cocaine carries significant risks of toxic cardiovascular complications. 1
Why Cocaine Should Be Avoided
Cardiovascular Toxicity
Cocaine can cause severe toxic cardiovascular complications even at low doses—significant toxic effects have been reported at doses as low as 20 mg in adults, despite the LD50 being 1.2 g. 1 Particular caution is required in:
- Older patients
- Those with cardiac disease
- Patients with hypertension or coronary artery disease
Unpredictable Absorption
Research demonstrates idiosyncratic absorption rates that can be four times greater than expected, with 47% of applied cocaine absorbed within the first 5 minutes and 70% within 10 minutes. 2 This unpredictable pharmacokinetic profile creates unacceptable safety risks.
Legal and Practical Concerns
- Cocaine remains detectable in blood above legal driving limits in 3% of patients and in saliva in 13% of patients at 24 hours post-administration 3
- 83% of patients express concerns about cocaine's illicit status affecting work and driving 4
- Cocaine is a controlled substance requiring special handling and documentation
Recommended Alternative: Co-Phenylcaine
Use lidocaine 5% combined with phenylephrine 0.5% (co-phenylcaine) instead. 1
Dosing for Co-Phenylcaine
- Standard preparation: 2.5 mL containing lidocaine 50 mg/mL + phenylephrine 5 mg/mL
- Provides lidocaine 125 mg + phenylephrine 12.5 mg per bottle 1
- Onset: 2-5 minutes
- Duration: 30 minutes to 1.5-2 hours
Lidocaine Safety Parameters
- Maximum dose: <9 mg/kg lean body weight 1
- This is a ceiling, not a target—lower doses are often effective
- Account for ALL local anesthetic sources (regional blocks, surgical infiltration)
- Have lipid emulsion immediately available for local anesthetic systemic toxicity
Application Technique
- Apply topical vasoconstrictor to nasal passages first (Grade A recommendation) 1
- Use mucosal atomization device, spray-as-you-go, or pledgets soaked in solution
- Test adequacy of topicalization atraumatically (e.g., soft suction catheter) before instrumentation 1
If Cocaine Is Historically Used (Transition Away)
Historical Cocaine Dosing (For Reference Only—Not Recommended)
If cocaine must be referenced for transition purposes:
- Maximum dose: <1.5 mg/kg 1
- 10% cocaine solution: onset 1-3 minutes, duration 30-60 minutes, terminal half-life 1 hour
- Avoid 10% solutions entirely—research advises against topical use of 10% cocaine due to idiosyncratic absorption and cardiovascular events 2
- Even 4% solutions for 20 minutes showed hypertension in 16.6% of patients 2
Absolute Contraindications to Cocaine
- Severe hypertension
- Severe coronary artery disease
- Cardiac arrhythmias
- Recent cocaine abuse (risk of myocardial dysfunction and pulmonary edema when combined with topical phenylephrine) 5
- Concurrent use with β-blockers (can precipitate pulmonary edema and cardiac arrest) 5
Critical Safety Considerations
Avoid β-Blocker Coadministration
Never treat cocaine-induced hypertension with β-blocking agents. 5 Multiple case reports document pulmonary edema, cardiac arrest, and death following β-blocker administration for cocaine-induced hypertension. The mechanism involves:
- α-adrenergic stimulation increases peripheral vascular resistance
- Blood shifts into pulmonary vasculature
- β-blockade prevents compensatory tachycardia and increased contractility
- Results in acute left ventricular failure
If hypertension occurs from any topical vasoconstrictor, increase volatile anesthetic concentration or use α-blocking agents—not β-blockers.
Emergency Preparedness
- Lipid emulsion must be immediately available
- Resuscitation equipment at bedside
- Continuous monitoring during and after application
- High index of suspicion for local anesthetic systemic toxicity
Evidence Quality
The recommendation against cocaine is based on:
- Grade A evidence from the 2020 Difficult Airway Society guidelines (highest quality, most recent) 1
- Randomized controlled trial showing no difference in pain between cocaine and lidocaine/xylometazoline 6
- Multiple prospective studies demonstrating unpredictable cocaine absorption and cardiovascular toxicity 2, 7
The evidence consistently demonstrates that phenylephrine combined with lidocaine is more appropriate than cocaine for nasal procedures, offering equivalent efficacy without the cardiovascular risks, legal complications, or unpredictable absorption profile.